The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils.
Open accessAbstract
Human neutrophils, monocytes, and eosinophils are known to undergo apoptotic cell death. The Fas/Fas ligand pathway has been implicated as an important cellular pathway mediating apoptosis in diverse cell types. We conducted studies to examine the importance of the Fas/FasL system in normal human phagocytes. Although Fas expression was detected on neutrophils, monocytes, and eosinophils, constitutive expression of FasL was restricted to neutrophils. The three types of phagocytes demonstrated differential sensitivity to Fas-induced apoptosis. Only neutrophils were highly susceptible to rapid apoptosis in vitro after stimulation with activating anti-Fas IgM (mAb CH-11). Fas-mediated neutrophil apoptosis was suppressed by incubation with G-CSF, GM-CSF, IFN-gamma, TNF-alpha, or dexamethasone, as well as the selective tyrosine kinase inhibitors, herbimycin A and genistein. Spontaneous neutrophil death in vitro was partially suppressed by Fas-Ig fusion protein or antagonistic anti-Fas IgG1 (mAb ZB4). In coculture experiments, neutrophils released a soluble factor inducing death in Fas-susceptible Jurkat cells via a mechanism sensitive to the presence of Fas-Ig or anti-Fas IgG1. Immunoblot analysis using specific anti-human FasL IgG1 (mAb No. 33) identified a 37-kD protein in lysates of freshly isolated neutrophils and a 30-kD protein in the culture supernatant of neutrophils maintained in vitro. Our results suggest that mature neutrophils may be irrevocably committed to autocrine death by virtue of their constitutive coexpression of cell-surface Fas and FasL via a mechanism that is sensitive to proinflammatory cytokines, glucocorticoids, and inhibitors of tyrosine kinase activity. Furthermore, neutrophils can serve as a source of soluble FasL, which may function in a paracrine pathway to mediate cell death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nagata, S., & Golstein, P. (1995) · Science · doi:10.1126/science.7533326 · Cited by 3,979
Genistein, a specific inhibitor of tyrosine-specific protein kinases.
Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., & Fukami, Y. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45614-1 · Cited by 3,724
Fadok, V. A., Voelker, D. R., Campbell, P. A., Cohen, J. J., Bratton, D. L., & Henson, P. M. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.7.2207 · Cited by 3,316
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
Boise, L. H., González-García, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nuñez, G., & Thompson, C. B. (1993) · Cell · doi:10.1016/0092-8674(93)90508-n · Cited by 3,087
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S.-I., Sameshima, M., Hase, A., Seto, Y., & Nagata, S. (1991) · Cell · doi:10.1016/0092-8674(91)90614-5 · Cited by 2,737
Koopman, G., Reutelingsperger, C., Kuijten, G., Keehnen, R., Pals, S., & van Oers, M. (1994) · Blood · doi:10.1182/blood.v84.5.1415.1415 · Cited by 2,681
Suda, T., Takahashi, T., Golstein, P., & Nagata, S. (1993) · Cell · doi:10.1016/0092-8674(93)90326-l · Cited by 2,489
Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
Dhein, J., Walczak, H., Bäumler, C., Debatin, K.-M., & Krammer, P. H. (1995) · Nature · doi:10.1038/373438a0 · Cited by 1,609
Fas and Perforin Pathways as Major Mechanisms of T Cell-Mediated Cytotoxicity
Kägi, D., Vignaux, F., Ledermann, B., Bürki, K., Depraetere, V., Nagata, S., Hengartner, H., & Golstein, P. (1994) · Science · doi:10.1126/science.7518614 · Cited by 1,516
Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation
Ju, S.-T., Panka, D. J., Cui, H., Ettinger, R., EI-Khatib, M., Sherr, D. H., Stanger, B. Z., & Marshak-Rothstein, A. (1995) · Nature · doi:10.1038/373444a0 · Cited by 1,499
Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubi, A., Echeverri, F., Martin, S. J., Force, W. R., Lynch, D. H., Ware, C. F., et al. (1995) · Nature · doi:10.1038/373441a0 · Cited by 1,314
Massive Cell Death of Immature Hematopoietic Cells and Neurons in Bcl-x-Deficient Mice
Motoyama, N., Wang, F., Roth, K. A., Sawa, H., Nakayama, K.-I., Nakayama, K., Negishi, I., Senju, S., Zhang, Q., Fujii, S., et al. (1995) · Science · doi:10.1126/science.7878471 · Cited by 1,163
Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products
Colotta, F., Re, F., Polentarutti, N., Sozzani, S., & Mantovani, A. (1992) · Blood · doi:10.1182/blood.v80.8.2012.2012 · Cited by 1,158
Linsley, P. S., Brady, W., Grosmaire, L., Aruffo, A., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.721 · Cited by 1,127
Self-citationCytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways
Lowin, B., Hahne, M., Mattmann, C., & Tschopp, J. (1994) · Nature · doi:10.1038/370650a0 · Cited by 1,051
Fas ligand mediates activation-induced cell death in human T lymphocytes.
Alderson, M. R., Tough, T. W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K. A., Goodwin, R. G., Smith, C. A., Ramsdell, F., & Lynch, D. H. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.71 · Cited by 934
Malech, H. L., & Gallin, J. I. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709103171107 · Cited by 838
Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity.
Rouvier, E., Luciani, M. F., & Golstein, P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.1.195 · Cited by 787
Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., et al. (1996) · Nature Medicine · doi:10.1038/nm0396-317 · Cited by 666
Expression of the functional soluble form of human fas ligand in activated lymphocytes.
Tanaka, M., Suda, T., Takahashi, T., & Nagata, S. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07096.x · Cited by 638
Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase.
Cifone, M. G., De Maria, R., Roncaioli, P., Rippo, M. R., Azuma, M., Lanier, L. L., Santoni, A., & Testi, R. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1547 · Cited by 573
Programmed Cell Death in the Immune System
Cohen, J. J. (1991) · Advances in Immunology · doi:10.1016/s0065-2776(08)60822-6 · Cited by 560
Purification and characterization of the Fas-ligand that induces apoptosis.
Suda, T., & Nagata, S. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.873 · Cited by 507
Cox, G. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.9.4719 · Cited by 505
CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+T cells
Rathmell, J. C., Cooke, M. P., Ho, W. Y., Grein, J., Townsend, S. E., Davis, M. M., & Goodnow, C. C. (1995) · Nature · doi:10.1038/376181a0 · Cited by 469
Homburg, C., de Haas, M., von dem Borne, A., Verhoeven, A., Reutelingsperger, C., & Roos, D. (1995) · Blood · doi:10.1182/blood.v85.2.532.532 · Cited by 431
Effect of bcl-2 on Fas antigen-mediated cell death.
Itoh, N., Tsujimoto, Y., & Nagata, S. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.2.621 · Cited by 428
Bcl-XL and Bcl-2 repress a common pathway of cell death.
Chao, D. T., Linette, G. P., Boise, L. H., White, L. S., Thompson, C. B., & Korsmeyer, S. J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.821 · Cited by 395
Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity.
Stalder, T., Hahn, S., & Erb, P. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.3.1127 · Cited by 373
Brach, M., deVos, S., Gruss, H., & Herrmann, F. (1992) · Blood · doi:10.1182/blood.v80.11.2920.2920 · Cited by 359
Fas and Fas Ligand: A Death Factor and Its Receptor
Nagata, S. (1994) · Advances in Immunology · doi:10.1016/s0065-2776(08)60672-0 · Cited by 338
Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system.
el-Hag, A., & Clark, R. A. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.7.2406 · Cited by 319
Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity.
Tepper, C. G., Jayadev, S., Liu, B., Bielawska, A., Wolff, R., Yonehara, S., Hannun, Y. A., & Seldin, M. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8443 · Cited by 316
Glucocorticoids inhibit apoptosis of human neutrophils
Liles, W., Dale, D., & Klebanoff, S. (1995) · Blood · doi:10.1182/blood.v86.8.3181.3181 · Cited by 315
Self-citationIwai, K., Miyawaki, T., Takizawa, T., Konno, A., Ohta, K., Yachie, A., Seki, H., & Taniguchi, N. (1994) · Blood · doi:10.1182/blood.v84.4.1201.1201 · Cited by 314
Stern, M., Meagher, L., Savill, J., & Haslett, C. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.11.3543 · Cited by 292
Mangan, D. F., & Wahl, S. M. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.10.3408 · Cited by 284
bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages.
Lagasse, E., & Weissman, I. L. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.1047 · Cited by 274
TCR/CD3 coupling to Fas-based cytotoxicity.
Vignaux, F., Vivier, E., Malissen, B., Depraetere, V, Nagata, S., & Golstein, P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.781 · Cited by 187
Fas ligation triggers apoptosis in macrophages but not endothelial cells
Richardson, B. C., Lalwani, N. D., Johnson, K. J., & Marks, R. M. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241111 · Cited by 183
Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis.
Eischen, C. M., Dick, C. J., & Leibson, P. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.5.1947 · Cited by 174
Alam, R., Forsythe, P., Stafford, S. J., & Fukuda, Y. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.3.1041 · Cited by 160
Regulation of cell adhesion molecule expression and function associated with neutrophil apoptosis
Dransfield, I., Stocks, S. C., & Haslett, C. (1995) · Blood · doi:10.1182/blood.v85.11.3264.bloodjournal85113264 · Cited by 156
Mower, D. A., Peckham, D. W., Illera, V. A., Fishbaugh, J., Stunz, L. L., & Ashman, R. F. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.4832 · Cited by 151
Vignaux, F., & Golstein, P. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240421 · Cited by 151
Transient elevations of cytosolic free calcium retard subsequent apoptosis in neutrophils in vitro.
Whyte, M. K. B., Hardwick, S. J., Meagher, L., Savill, J., & Haslett, C. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116587 · Cited by 141
Regulation of apoptosis in neutrophils--Fas track to death?
Liles, W. C., & Klebanoff, S. J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.7.3289 · Cited by 115
Self-citationInterleukin‐2 prevention of apoptosis in human neutrophils
Pericle, F., Liu, J. H., Blanchard, D. K., Wei, S., Djeu, J. Y., Diaz, J. I., & Forni, G. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240226 · Cited by 110
Primitive human hematopoietic precursors express Bcl-x but not Bcl-2
Park, J., Bernstein, I. D., & Hockenbery, D. M. (1995) · Blood · doi:10.1182/blood.v86.3.868.868 · Cited by 99
Park, J., Robertson, K. A., Hickstein, D., Tsai, S., Hockenbery, D. M., & Collins, S. (1994) · Blood · doi:10.1182/blood.v84.2.440.440 · Cited by 98
Separate metabolic pathways leading to DNA fragmentation and apoptotic chromatin condensation.
Sun, D., Jiang, S., Zheng, L., et al. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.2.559 · Cited by 97
Oshimi, Y., & Miyazaki, S. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.2.599 · Cited by 90
The target cell nucleus is not required for cell-mediated granzyme- or Fas-based cytotoxicity.
Nakajima, H., Golstein, P., & Henkart, P. A. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.5.1905 · Cited by 90
Gillette‐Ferguson, I., & Sidman, C. L. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240526 · Cited by 80
Liles, W. C., Ledbetter, J. A., Waltersdorph, A. W., & Klebanoff, S. J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.4.2175 · Cited by 47
Self-citation
Cited by
Inflammation and aging: signaling pathways and intervention therapies
Li, X., Li, C., Zhang, W., Wang, Y., Qian, P., & Huang, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01502-8 · Cited by 1,443
Caspase-3-Generated Fragment of Gelsolin: Effector of Morphological Change in Apoptosis
Kothakota, S., Azuma, T., Reinhard, C., Klippel, A., Tang, J., Chu, K., McGarry, T. J., Kirschner, M. W., Koths, K., Kwiatkowski, D. J., et al. (1997) · Science · doi:10.1126/science.278.5336.294 · Cited by 1,225
Macrophage Dysfunction Impairs Resolution of Inflammation in the Wounds of Diabetic Mice
Khanna, S., Biswas, S., Shang, Y., Collard, E., Azad, A., Kauh, C., Bhasker, V., Gordillo, G. M., Sen, C. K., & Roy, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009539 · Cited by 694
Passegué, E., Jamieson, C. H. M., Ailles, L. E., & Weissman, I. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2034201100 · Cited by 686
Apoptosis in resolution of inflammation
Savill, J. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.61.4.375 · Cited by 652
Metadata
- Authors
- Liles, W. C., Kiener, P. A., Ledbetter, J. A., Aruffo, A., & Klebanoff, S. J.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1996-08-01
- Volume
- 184
- Issue
- 2
- Pages
- 429-440
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2116172091
- Cited by
- 557
- References
- 55
- FWCI
- 17.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.